SynBioBeta

In a strategic move to enhance its oncology portfolio, Gilead Sciences has agreed to acquire Arcellx for an implied equity value of $7.8 billion, securing full ownership of the late-stage CAR T therapy anitocabtagene autoleucel (anito-cel). This acquisition consolidates Arcellx's innovative D-Domain platform with Gilead's established cell therapy infrastructure, positioning the company to accelerate development and commercialization efforts ahead of the therapy's FDA decision expected by December 2026. news.biobuzz.io/2026/02/23/bre… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…

Manus has expanded its partnership with the U.S. Department of Health and Human Services, receiving an additional $15 million to enhance domestic production of shikimic acid, a vital component for oseltamivir, the active ingredient in Tamiflu. This funding aims to strengthen U.S. health security by reducing reliance on foreign supply chains, addressing a critical vulnerability, as over 80% of essential medicine ingredients are sourced overseas. manusbio.com/articles/manus… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…

Turbine has raised $25 million in a Series B round led by Interactive Venture Partners, with participation from Beiersdorf Venture Capital and other existing investors. The funding will enhance Turbine's virtual cell platform and support a new partnership with a top 10 pharmaceutical company to model immune cell behavior, aiming to streamline the discovery of novel immunotherapy combinations. prnewswire.com/news-releases/… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…

JOYN Foods , formerly Mush Foods, plans to triple revenues in 2026 and achieve EBITDA positivity by early 2027, leveraging its cost-effective mycelium-based meat blends to capture the price-sensitive foodservice market. With monthly sales exceeding $250k and partnerships with major suppliers like Sysco and US Foods, JOYN's 50CUT brand is gaining traction in K-12 cafeterias following recent approval from the South Carolina Purchasing Alliance. agfundernews.com/hybrid-meat-fo… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…

French startup Verley has raised €32M ($37.6M) in Series A funding to scale production of its precision-fermented, cow-free whey proteins, targeting the U.S. market with initial product launches by the end of 2026. The oversubscribed round was led by Alven, with additional backing from Bpifrance and others, positioning Verley to meet increasing demand for high-protein alternatives amid a tightening supply of conventional whey. greenqueen.com.hk/verley-precisi… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…

A universal antivenom sounds ambitious — which is exactly why it is worth paying attention to 🐍🧪🌍 📍SynBioBeta • May 4–7, 2026 • San Jose Register and join the conversation at SynBioBeta Register and join the conversation at SynBioBeta syntheticbiologysummit.com/?utm_source=x&… #SynBioBeta #Biomanufacturing #Engineering #StartupLife #SyntheticBiology

@Ginkgo Bioworks and @Invaio_Sciences have partnered to develop a microorganism capable of manufacturing peptide-based agricultural products, addressing the need for effective pest control as conventional methods become less viable. This collaboration leverages Ginkgo's advanced microbial strains and fermentation technology to optimize production processes, supporting Invaio's goal of delivering affordable and efficient crop protection solutions. prnewswire.com/news-releases/… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…

Only a small fraction goes toward proactive health — and that gap may be one of healthcare’s biggest opportunities 🏥📊🔬 📍SynBioBeta • May 4–7, 2026 • San Jose Register and join the conversation at SynBioBeta syntheticbiologysummit.com/?utm_source=x&… #SynBioBeta #Biomanufacturing #Engineering #StartupLife #SyntheticBiology

@DARPA has initiated the PROtein SEquencing (PROSE) program to develop integrated microsystems capable of directly reading complex proteins without relying on reference sequences. Over the next 36 months, three teams—Electronic Biosciences, Kostas Research Institute at Northeastern University, and Pumpkinseed—will work on innovative approaches to tackle the limitations of current protein sequencing technologies, paving the way for advancements in healthcare and national security. darpa.mil/news/2026/prot… Subscribe to our newsletter and get the biggest biotech news straight to your inbox. syntheticbiologysummit.com/?utm_source=X&…

John Cumbers discusses the transformative potential of AI in synthetic biology and the development of a universal antivenom derived from over 200 snake bites in a recent podcast. He highlights the upcoming SynBioBeta 2026 event in San Jose, which will showcase innovations in biomanufacturing and AI-driven drug development. amplafy.notion.site/169-AI-Antiven… Subscribe to our newsletter and get the biggest biotech news straight to your inbox. syntheticbiologysummit.com/?utm_source=X&…

The ideas that sound impossible at first are often the ones that move biotech forward fastest 💡🧬🚀 📍SynBioBeta • May 4–7, 2026 • San Jose Register and join the conversation at SynBioBeta syntheticbiologysummit.com/?utm_source=x&…